Clik here to view.
Isis Spinoff Ibis Biosciences, Looking at DNA of Infectious Bugs, Aims to...
Luke Timmerman When people walk into the hospital with nasty flu-like symptoms, and doctors don’t know where the bug came from, the custom is to take a fluid sample and grow it in a lab dish for a day...
View ArticleClik here to view.
Cadence Drug Fails to Prevent Hospital Infections; Company Scraps Program
Luke Timmerman Cadence Pharmaceuticals has taken a couple steps forward in the past few months, and now it took one step back. The San Diego-based biotech company (NASDAQ: CADX) said today the second...
View ArticleClik here to view.
Pico Pharmaceuticals, In Its Early Days, Aims to Make More Potent Cancer...
Luke Timmerman One out of three biotech companies in the U.S. are running down to their last six months of cash, but biotech entrepreneurs are continuing to start new companies. The latest one to...
View ArticleClik here to view.
Cubist to Acquire Calixa Therapeutics in Deal Worth up to $402.5M
Ryan McBride Lexington, MA-based Cubist Pharmaceuticals says today that it’s inked a deal to buy fellow antiobiotic drug developer Calixa Therapeutics, of San Diego, for $92.5 million upfront and up...
View ArticleClik here to view.
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build...
Ryan McBride Tumors are kicking our butt in the war on cancer. What’s more, big drugmakers are cutting their budgets at the expense of some cancer treatments under development. But now there’s Tesaro,...
View ArticleClik here to view.
Trius Chops IPO Price, Offers More Shares
Bruce V. Bigelow In a page taken from the discount retailing playbook, San Diego’s Trius Therapeutics slashed the proposed price of its pending IPO by roughly 60 percent and increased the number of...
View ArticleClik here to view.
FDA Clears New Version of Tyrx’s Infection-Fighting Pacemaker Sleeve
Ben Fidler Tyrx climbed its first big hurdle in 2008 when it began selling its first product to hospitals in the U.S. With a key green light today from the Food and Drug Administration, the Monmouth...
View ArticleClik here to view.
San Diego’s Telephus Seeks $5M to Advance Anti-Infective Antibody
Bruce V. Bigelow According to Greek mythology, “the wound that would not heal” was inflicted by the intemperate warrior Achilles when he fell upon Telephus, son of Hercules, after invading an allied...
View ArticleClik here to view.
How to Make Healthcare Better? Make It Easy
There’s an “easy button” in the hospital that I press a hundred times every day. With each press, I make myself a better doctor. It’s not a button on a computer. It’s not electronic at all. It’s a...
View ArticleClik here to view.
San Antonio’s Xenex Debuts Hospital-Cleaning “Pod” After Adding $38M
San Antonio — Xenex Disinfection Services, a healthcare company that raised $38 million in February, is now selling a new device for its machine that rids hospital rooms of infection-causing bacteria...
View ArticleClik here to view.
Zurex Pharma Raises $9M to Fight Hospital-Acquired Infections
Zurex Pharma, a Middleton, WI-based company developing antimicrobial products for preventing infections acquired in hospitals, clinics, and home care settings, says it has raised $9 million in new...
View ArticleClik here to view.
FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs
[Updated 7:25 p.m. See below.] Safety concerns stymied Sarepta Therapeutics’ attempt to win FDA approval last August for golodirsen (Vyondys 53), its second Duchenne muscular dystrophy drug. But an...
View Article
